These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 37662901)

  • 21. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.
    Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N
    Front Immunol; 2014; 5():180. PubMed ID: 24795723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois.
    Udoakang AJ; Djomkam Zune AL; Tapela K; Nganyewo NN; Olisaka FN; Anyigba CA; Tawiah-Eshun S; Owusu IA; Paemka L; Awandare GA; Quashie PK
    Front Immunol; 2023; 14():1104828. PubMed ID: 36776887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
    Coppola M; Ottenhoff TH
    Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities.
    Siranart N; Sowalertrat W; Sukonpatip M; Suwanpimolkul G; Torvorapanit P
    J Infect Public Health; 2023 Jan; 16(1):80-89. PubMed ID: 36495816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2.
    Rosas Mejia O; Gloag ES; Li J; Ruane-Foster M; Claeys TA; Farkas D; Wang SH; Farkas L; Xin G; Robinson RT
    PLoS Pathog; 2022 Mar; 18(3):e1010093. PubMed ID: 35325013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of tuberculosis/COVID-19 co-infection and factors associated with SARS-CoV-2 infection in pulmonary tuberculosis patients at a respiratory diseases center: a cross-sectional study.
    Mangamba LE; Sike CIM; Tochie JN; Dalle GN; Nkouagmi N; Balkissou AD; Bille BE; Ngahane BHM; Moukoko CEE
    Pan Afr Med J; 2023; 44():204. PubMed ID: 37484595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status in cellular-based therapies for prevention and treatment of COVID-19.
    Hattab D; Amer MFA; Mohd Gazzali A; Chuah LH; Bakhtiar A
    Crit Rev Clin Lab Sci; 2023 Aug; 60(5):321-345. PubMed ID: 36825325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis/COVID-19 co-infection detected in a single sputum sample using a rapid molecular test.
    Guirelli AO; Bispo TR; Colpas DR; de Campos IB; Chimara E; Cergole-Novella MC; Rodart IF; Dos Santos Candido V; Segura-Ramírez PJ; Dos Santos Menezes Gaiotto Daros V; Dos Santos Carmo AM
    Braz J Microbiol; 2022 Jun; 53(2):633-639. PubMed ID: 35107805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models for COVID-19 and tuberculosis.
    Corleis B; Bastian M; Hoffmann D; Beer M; Dorhoi A
    Front Immunol; 2023; 14():1223260. PubMed ID: 37638020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses.
    Goletti D; Petrone L; Manissero D; Bertoletti A; Rao S; Ndunda N; Sette A; Nikolayevskyy V
    Clin Microbiol Infect; 2021 Dec; 27(12):1784-1789. PubMed ID: 34256141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
    Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
    Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and Cellular Mechanisms of
    Starshinova AA; Kudryavtsev I; Malkova A; Zinchenko U; Karev V; Kudlay D; Glushkova A; Starshinova AY; Dominguez J; Villar-Hernández R; Dovgalyk I; Yablonskiy P
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential activation of innate and adaptive lymphocytes during latent or active infection with Mycobacterium tuberculosis.
    Ruiz-Sánchez BP; Castañeda-Casimiro J; Cabrera-Rivera GL; Brito-Arriola OM; Cruz-Zárate D; García-Paredes VG; Casillas-Suárez C; Serafín-López J; Chacón-Salinas R; Estrada-Parra S; Escobar-Gutiérrez A; Estrada-García I; Hernández-Solis A; Wong-Baeza I
    Microbiol Immunol; 2022 Oct; 66(10):477-490. PubMed ID: 35856253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy.
    Musso M; Di Gennaro F; Gualano G; Mosti S; Cerva C; Fard SN; Libertone R; Di Bari V; Cristofaro M; Tonnarini R; Castilletti C; Goletti D; Palmieri F
    Infection; 2021 Oct; 49(5):1061-1064. PubMed ID: 33454928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response to SARS-CoV-2 variants: A focus on severity, susceptibility, and preexisting immunity.
    Alefishat E; Jelinek HF; Mousa M; Tay GK; Alsafar HS
    J Infect Public Health; 2022 Feb; 15(2):277-288. PubMed ID: 35074728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
    González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
    Viruses; 2021 May; 13(5):. PubMed ID: 34067925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapidly Evolving and Fatal Miliary Tuberculosis and COVID-19 Infection in an Infant.
    Ghosh A; Tchakarov A; Pérez N; Tatevian N; Bhattacharjee M
    Ann Clin Lab Sci; 2022 Sep; 52(5):831-837. PubMed ID: 36261183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.